Actinium Pharmaceuticals
ATNM
#9343
Rank
HK$0.35 B
Marketcap
HK$11.44
Share price
5.76%
Change (1 day)
-65.95%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -HK$0.37 Billion

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are HK$0.08 Million. In 2023 the company made an earning of -HK$0.41 Billion a decrease over its 2022 earnings that were of -HK$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.37 Billion-9.59%
2023 -HK$0.41 Billion52.24%
2022 -HK$0.27 Billion36.61%
2021 -HK$0.2 Billion11.48%
2020 -HK$0.18 Billion1.46%
2019 -HK$0.18 Billion-7.37%
2018 -HK$0.19 Billion-11.46%
2017 -HK$0.21 Billion10.67%
2016 -HK$0.19 Billion15.7%
2015 -HK$0.17 Billion-14.86%
2014 -HK$0.2 Billion129.19%
2013 -HK$83.82 Million-8.55%
2012 -HK$91.66 Million
2010 HK$0.06 M-152.15%
2009 -HK$0.13 Million-39.8%
2008 -HK$0.21 Million120.29%
2007 -HK$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.29 Billion-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.04 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.78 Billion 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA